This work is licensed under the Creative Commons Attribution 4.0 International License.
Mizushima N. Autophagy: process and function. Genes Dev. 2007; 21:2861–73.MizushimaNAutophagy: process and function200721286173Search in Google Scholar
Knaevelsrud H, Ahlquist T, Merok MA, Nesbakken A, Stenmark H, Lothe RA, Simonsen A. UVRAG mutations associated with microsatellite unstable colon cancer do not affect autophagy. Autophagy. 2010; 6:863–70.KnaevelsrudHAhlquistTMerokMANesbakkenAStenmarkHLotheRASimonsenAUVRAG mutations associated with microsatellite unstable colon cancer do not affect autophagy2010686370Search in Google Scholar
Amaravadi RK, Lippincott-Schwartz J, Yin XM, Weiss WA, Takebe N, Timmer W, et al. Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res. 2011; 17:654–66.AmaravadiRKLippincott-SchwartzJYinXMWeissWATakebeNTimmerWPrinciples and current strategies for targeting autophagy for cancer treatment20111765466Search in Google Scholar
Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008; 132:27–42.LevineBKroemerGAutophagy in the pathogenesis of disease20081322742Search in Google Scholar
Lorin S, Hamaï A, Mehrpour M, Codogno P. Autophagy regulation and its role in cancer. Semin Cancer Biol. 2013; 23:361–7.LorinSHamaïAMehrpourMCodognoPAutophagy regulation and its role in cancer2013233617Search in Google Scholar
White E, Karp C, Strohecker AM, Guo Y, Mathew R. Role of autophagy in suppression of inflammation and cancer. Curr Opin Cell Biol. 2010; 22:212–7.WhiteEKarpCStroheckerAMGuoYMathewRRole of autophagy in suppression of inflammation and cancer2010222127Search in Google Scholar
Mathew R, Kongara S, Beaudoin B, Karp CM, Bray K, Degenhardt K, et al. Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev. 2007; 21:1367–81.MathewRKongaraSBeaudoinBKarpCMBrayKDegenhardtKAutophagy suppresses tumor progression by limiting chromosomal instability200721136781Search in Google Scholar
Saha S, Panigrahi DP, Patil S, Bhutia SK. Autophagy in health and disease: a comprehensive review. Biomed Pharmacother. 2018; 104:485–95.SahaSPanigrahiDPPatilSBhutiaSKAutophagy in health and disease: a comprehensive review201810448595Search in Google Scholar
Kang MR, Kim MS, Oh JE, Kim YR, Song SY, Kim SS, et al. Frameshift mutations of autophagy-related genes ATG2B, ATG5, ATG9B and ATG12 in gastric and colorectal cancers with microsatellite instability. J Pathol. 2009; 217:702–6.KangMRKimMSOhJEKimYRSongSYKimSSFrameshift mutations of autophagy-related genes ATG2B, ATG5, ATG9B and ATG12 in gastric and colorectal cancers with microsatellite instability20092177026Search in Google Scholar
Lu D, Yang C, Zhang Z, Cong Y, Xiao M. Knockdown of linc00515 inhibits multiple myeloma autophagy and chemoresistance by upregulating miR-140-5p and downregulating ATG14. Cell Physiol Biochem. 2018; 48:2517–27.LuDYangCZhangZCongYXiaoMKnockdown of linc00515 inhibits multiple myeloma autophagy and chemoresistance by upregulating miR-140-5p and downregulating ATG14201848251727Search in Google Scholar
MAQC Consortium. The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol. 2010; 28:827–38.MAQC ConsortiumThe MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models20102882738Search in Google Scholar
Usmani SZ, Sexton R, Hoering A, Heuck CJ, Nair B, Waheed S, et al. Second malignancies in total therapy 2 and 3 for newly diagnosed multiple myeloma: influence of thalidomide and lenalidomide during maintenance. Blood. 2012; 120:1597–600.UsmaniSZSextonRHoeringAHeuckCJNairBWaheedSSecond malignancies in total therapy 2 and 3 for newly diagnosed multiple myeloma: influence of thalidomide and lenalidomide during maintenance20121201597600Search in Google Scholar
Nahi H, Sutlu T, Jansson M, Alici E, Gahrton G. Clinical impact of chromosomal aberrations in multiple myeloma. J Intern Med. 2011; 269:137–47.NahiHSutluTJanssonMAliciEGahrtonGClinical impact of chromosomal aberrations in multiple myeloma201126913747Search in Google Scholar
Avet-Loiseau H, Li C, Magrangeas F, Gouraud W, Charbonnel C, Harousseau JL, et al. Prognostic significance of copy-number alterations in multiple myeloma. J Clin Oncol. 2009; 27:4585–90.Avet-LoiseauHLiCMagrangeasFGouraudWCharbonnelCHarousseauJLPrognostic significance of copy-number alterations in multiple myeloma200927458590Search in Google Scholar
Van Wier S, Braggio E, Baker A, Ahmann G, Levy J, Carpten JD, Fonseca R. Hypodiploid multiple myeloma is characterized by more aggressive molecular markers than non-hyperdiploid multiple myeloma. Haematologica. 2013; 98:1586–92.Van WierSBraggioEBakerAAhmannGLevyJCarptenJDFonsecaRHypodiploid multiple myeloma is characterized by more aggressive molecular markers than non-hyperdiploid multiple myeloma201398158692Search in Google Scholar
Zhang Y, Chen XL, Chen WM, Zhou HB. Prognostic nomogram for the overall survival of patients with newly diagnosed multiple myeloma. Biomed Res Int. 2019; 8:5652935. doi: 10.1155/2019/5652935ZhangYChenXLChenWMZhouHBPrognostic nomogram for the overall survival of patients with newly diagnosed multiple myeloma20198565293510.1155/2019/5652935Open DOISearch in Google Scholar
Kumar S, Fonseca R, Ketterling RP, Dispenzieri A, Lacy MQ, Gertz MA, et al. Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics. Blood. 2012; 119:2100–5.KumarSFonsecaRKetterlingRPDispenzieriALacyMQGertzMATrisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics201211921005Search in Google Scholar
Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017; 67:93–9.AminMBGreeneFLEdgeSBComptonCCGershenwaldJEBrooklandRKThe eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging201767939Search in Google Scholar
Zhang BH, Yang J, Jiang L, Lyu T, Kong LX, Tan YF, et al. Development and validation of a 14-gene signature for prognosis prediction in hepatocellular carcinoma. Genomics. 2020; 112:2763–71. doi: 10.1016/j.ygeno.2020.03.013ZhangBHYangJJiangLLyuTKongLXTanYFDevelopment and validation of a 14-gene signature for prognosis prediction in hepatocellular carcinoma202011227637110.1016/j.ygeno.2020.03.013Open DOISearch in Google Scholar
Hu D, Jiang L, Luo S, Zhao X, Hu H, Zhao G, Tang W. Development of an autophagy-related gene expression signature for prognosis prediction in prostate cancer patients. J Transl Med. 2020; 18:160. doi: 10.1186/s12967-020-02323-xHuDJiangLLuoSZhaoXHuHZhaoGTangWDevelopment of an autophagy-related gene expression signature for prognosis prediction in prostate cancer patients20201816010.1186/s12967-020-02323-xOpen DOISearch in Google Scholar
Lin P, He RQ, Dang YW, Wen DY, Ma J, He Y, et al. An autophagy-related gene expression signature for survival prediction in multiple cohorts of hepatocellular carcinoma patients. Oncotarget. 2018; 9:17368–95.LinPHeRQDangYWWenDYMaJHeYAn autophagy-related gene expression signature for survival prediction in multiple cohorts of hepatocellular carcinoma patients201891736895Search in Google Scholar
Huang Z, Liu J, Luo L, Sheng P, Wang B, Zhang J, Peng SS. Genome-wide identification of a novel autophagy-related signature for colorectal cancer. Dose Response. 2019; 17:1559325819894179. doi: 10.1177/1559325819894179HuangZLiuJLuoLShengPWangBZhangJPengSSGenome-wide identification of a novel autophagy-related signature for colorectal cancer201917155932581989417910.1177/1559325819894179Open DOISearch in Google Scholar
Lin QG, Liu W, Mo YZ, Han J, Guo ZX, Zheng W, et al. Development of prognostic index based on autophagy-related genes analysis in breast cancer. Aging (Albany NY). 2020; 12:1366–76.LinQGLiuWMoYZHanJGuoZXZhengWDevelopment of prognostic index based on autophagy-related genes analysis in breast cancer202012136676Search in Google Scholar
Zhu FX, Wang XT, Zeng HQ, Yin ZH, Ye ZZ. A predicted risk score based on the expression of 16 autophagy-related genes for multiple myeloma survival. Oncol Lett. 2019; 18:5310–24.ZhuFXWangXTZengHQYinZHYeZZA predicted risk score based on the expression of 16 autophagy-related genes for multiple myeloma survival201918531024Search in Google Scholar
McGranahan N, Burrell RA, Endesfelder D, Novelli MR, Swanton C. Cancer chromosomal instability: therapeutic and diagnostic challenges. EMBO Rep. 2012; 13:528–38.McGranahanNBurrellRAEndesfelderDNovelliMRSwantonCCancer chromosomal instability: therapeutic and diagnostic challenges20121352838Search in Google Scholar
Bakhoum SF, Cantley LC. The multifaceted role of chromosomal instability in cancer and its microenvironment. Cell. 2018; 174:1347–60.BakhoumSFCantleyLCThe multifaceted role of chromosomal instability in cancer and its microenvironment2018174134760Search in Google Scholar
Engelhardt M, Terpos E, Kleber M, Gay F, Wäsch R, Morgan G, et al. European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma. Haematologica. 2014; 99:232–42.EngelhardtMTerposEKleberMGayFWäschRMorganGEuropean Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma20149923242Search in Google Scholar
Palumbo A, Avet-Loiseau H, Oliva S, Lokhorst HM, Goldschmidt H, Rosinol L, et al. Revised international staging system for multiple myeloma: a report from international myeloma working group. J Clin Oncol. 2015; 33:2863–9.PalumboAAvet-LoiseauHOlivaSLokhorstHMGoldschmidtHRosinolLRevised international staging system for multiple myeloma: a report from international myeloma working group20153328639Search in Google Scholar
Neben K, Jauch A, Bertsch U, Heiss C, Hielscher T, Seckinger A, et al. Combining information regarding chromosomal aberrations t(4;14) and del(17pl3) with the international staging system classification allows stratification of myeloma patients undergoing autologous stem cell transplantation. Haematologica. 2010; 95:1150–7.NebenKJauchABertschUHeissCHielscherTSeckingerACombining information regarding chromosomal aberrations t(4;14) and del(17pl3) with the international staging system classification allows stratification of myeloma patients undergoing autologous stem cell transplantation20109511507Search in Google Scholar
Kalff A, Spencer A. The t(4;14) translocation and FGFR3 overexpression in multiple myeloma: prognostic implications and current clinical strategies. Blood Cancer J. 2012; 2:e89. doi: 10.1038/bcj.2012.37KalffASpencerAThe t(4;14) translocation and FGFR3 overexpression in multiple myeloma: prognostic implications and current clinical strategies20122e8910.1038/bcj.2012.37Open DOISearch in Google Scholar
Mei H, Xiang Y, Mei H, Fang B, Wang Q, Cao D, et al. Pterostilbene inhibits nutrient metabolism and induces apoptosis through AMPK activation in multiple myeloma cells. Int J Mol Med. 2018; 42:2676–88.MeiHXiangYMeiHFangBWangQCaoDPterostilbene inhibits nutrient metabolism and induces apoptosis through AMPK activation in multiple myeloma cells201842267688Search in Google Scholar
Desantis V, Saltarella I, Lamanuzzi A, Mariggiò MA, Racanelli V, Vacca A, Frassanito MA. Autophagy: a new mechanism of prosurvival and drug resistance in multiple myeloma. Transl Oncol. 2018; 11:1350–7.DesantisVSaltarellaILamanuzziAMariggiòMARacanelliVVaccaAFrassanitoMAAutophagy: a new mechanism of prosurvival and drug resistance in multiple myeloma20181113507Search in Google Scholar
Rozental A, Gafter-Gvili A, Vidal L, Raanani P, Gurion R. The role of maintenance therapy in patients with diffuse large B cell lymphoma: a systematic review and meta-analysis. Hematol Oncol. 2019; 37:27–34.RozentalAGafter-GviliAVidalLRaananiPGurionRThe role of maintenance therapy in patients with diffuse large B cell lymphoma: a systematic review and meta-analysis2019372734Search in Google Scholar
Ayna G, Krysko DV, Kaczmarek A, Petrovski G, Vandenabeele P, Fésüs L. ATP release from dying autophagic cells and their phagocytosis are crucial for inflammasome activation in macrophages. PLoS One. 2012; 7:e40069. doi: 10.1371/journal.pone.0040069AynaGKryskoDVKaczmarekAPetrovskiGVandenabeelePFésüsLATP release from dying autophagic cells and their phagocytosis are crucial for inflammasome activation in macrophages20127e4006910.1371/journal.pone.0040069Open DOISearch in Google Scholar
Lamy L, Ngo VN, Emre NC, Shaffer AL 3rd, Yang Y, Tian E, et al. Control of autophagic cell death by caspase-10 in multiple myeloma. Cancer Cell. 2013; 23:435–49.LamyLNgoVNEmreNCShafferAL3rdYangYTianEControl of autophagic cell death by caspase-10 in multiple myeloma20132343549Search in Google Scholar
Pullarkat V, Meng Z, Donohue C, Yamamoto VN, Tomassetti S, Bhatia R, et al. Iron chelators induce autophagic cell death in multiple myeloma cells. Leuk Res. 2014; 38:988–96.PullarkatVMengZDonohueCYamamotoVNTomassettiSBhatiaRIron chelators induce autophagic cell death in multiple myeloma cells20143898896Search in Google Scholar
Petrovski G, Ayna G, Majai G, Hodrea J, Benko S, Mádi A, Fésüs L. Phagocytosis of cells dying through autophagy induces inflammasome activation and IL-1β release in human macrophages. Autophagy. 2011; 7:321–30.PetrovskiGAynaGMajaiGHodreaJBenkoSMádiAFésüsLPhagocytosis of cells dying through autophagy induces inflammasome activation and IL-1β release in human macrophages2011732130Search in Google Scholar